Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Hyperpolarization-activated cyclic nucleotide-gated channel (HCN) blocker, Ivabradine, a novel potential targeted treatment for triple-negative breast cancer. Proceeding/Conference:European Journal of Cancer | 2018 | |||
KPNA1 mediates the nuclear import of BQ323636.1 and confer tamoxifen resistance in breast cancer cells Proceeding/Conference:Cancer Research | 2018 | 4 | ||
2020 | ||||
Translational regulation by eIF4E and its contribution to tamoxifen resistance in breast cancer Proceeding/Conference:Cancer Research | 2016 | 39 |